Rachel V Thomas

Health and Me

‘Ozempic Of Autism’: Experimental Drug Shows Symptom Improvements In Nonverbal Boy With ASD

Joshua, 27, was diagnosed with <a href="https://www.healthandme.com/health/autism">autism</a> at two and a half. He was nonverbal and experienced severe anxiety, while getting a full night's sleep remained a struggle for years.

An experimental drug called L1-79, touted as ‘Ozempic Of <a href="https://www.healthandme.com/health/autism" data-type="tilCustomLink">Autism</a>' has reportedly brought significant improvements in his condition, according to the Daily Mail, raising interest in its potential to address core features of autism spectrum disorder (ASD).

<h2>How Did The Drug L1-79 Help Joshua?</h2>

Developed by Yamo Pharmaceuticals, L1-79 is an oral drug designed to target core symptoms of autism.

Joshua’s psychiatrist of eight years, Dr. Eric Bartky, an autism specialist involved in the US FDA trial of L1-79, asked his parents Linda and Jim Turteltaub to consider trying the drug.

The decision involved uncertainty. Taking part in the trial required Joshua to stop all his other medications, and the potential side effects of the new treatment were not fully known. Despite these concerns, his parents decided in 2015 to give it a try.

“We just wanted something to address the issues, to try and get him better so that he can at least communicate with us,” Linda said.

According to the report, Joshua showed his first notable improvement within a week of beginning treatment.

Also read: <a href="https://www.healthandme.com/parenting/autism-care-begins-early-why-the-first-1000-days-matter-most-says-aiims-expert-article-154223267" data-type="tilCustomLink">Autism Care Begins Early: Why the First 1,000 Days Matter Most, Says AIIMS Expert</a>

Yamo Pharmaceuticals describes L1-79 as a selective inhibitor of tyrosine hydroxylase, an enzyme involved in the production of dopamine and norepinephrine.

The drug is intended to lower the production of these chemical messengers in an effort to regulate pathways that may contribute to sensory overload and social withdrawal in people with autism.

Dr. Bartky said the drug differs from existing approaches because it aims to address core features of autism, including social interaction and communication.

“What makes L1-79 different is that L1-79 treats the core symptoms of autism, things like socialization and communications, things that go along with that like eye contact, reciprocal conversation, nonverbal communication, such as reading social nuance. These are things that are extremely important for a person's emotional growth and functioning in society.”

The response to treatment has varied among Dr. Bartky's patients, reflecting the wide range of symptoms associated with ASD.

<h2>What Is The Status Of L1-79 Clinical Trials?</h2>

Read More: <a href="https://www.healthandme.com/health-news/stem-cell-therapy-for-autism-what-indias-new-advisory-means-for-patients-article-156172804" data-type="tilCustomLink">Stem Cell Therapy For Autism: What India’s New Advisory Means For Patients</a>

There is currently no single medication that treats all the core features of autism spectrum disorder. Several medications are prescribed to manage particular behavioral patterns and associated conditions.

L1-79 is being investigated as a potential treatment that could address autism's underlying neurological features. The Daily Mail reported that 116 patients had participated in L1-79's three clinical trials.

The drug has received Fast Track designation from the US Food and Drug Administration (FDA). This program is intended to facilitate the development and review of treatments for serious conditions that address unmet medical needs.

Although the designation does not shorten the clinical trial process, it can make a drug eligible for priority review. Under this pathway, the FDA aims to complete its review within six months, compared with the standard 10-month timeline. 

Dr. Bartky also pointed to what he described as L1-79's safety profile.

Some existing medications can cause serious side effects, including dyskinesia, which involves involuntary movements that can sometimes be permanent; metabolic syndrome, a group of conditions associated with increased risks of heart disease, stroke and type 2 diabetes; and hypertension. Dr. Bartky said L1-79 had “not had one single serious side effect.”

Health Conditions A-Z

health

ozempic-of-autism-experimental-drug-shows-symptom-improvements-in-nonverbal-boy-with-asd

Ozempic

Autism

Ozempic Of Autism

yamo pharmaceuticals

L1 79

autism spectrum disorder

joshua

eric bartky

paper-straws-have-633-times-higher-carcinogenic-risk-than-plastic-straws-study-finds

Paper Straws Have 6.33 Times Higher Carcinogenic Risk Than Plastic Straws, Study Finds

can-electrical-shocks-to-the-brain-reduce-mens-tendency-to-sexualise-women-new-study-finds-change

Can Electrical Shocks To The Brain Reduce Men’s Tendency To Sexualise Women? New Study Finds Change

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Joshua, 27, was diagnosed with autism at two and a half. He was nonverbal and experienced severe anxiety, while getting a full night's sleep remained a struggle for years.An experimental drug called L1-79, touted as ‘Ozempic Of Autism' has reportedly brought significant improvements in his condition, according to the Daily Mail, raising interest in its potential to address core features of autism spectrum disorder (ASD).How Did The Drug L1-79 Help Joshua?Developed by Yamo Pharmaceuticals, L1-79 is an oral drug designed to target core symptoms of autism.Joshua’s psychiatrist of eight years, Dr. Eric Bartky, an autism specialist involved in the US FDA trial of L1-79, asked his parents Linda and Jim Turteltaub to consider trying the drug.The decision involved uncertainty. Taking part in the trial required Joshua to stop all his other medications, and the potential side effects of the new treatment were not fully known. Despite these concerns, his parents decided in 2015 to give it a try.“We just wanted something to address the issues, to try and get him better so that he can at least communicate with us,” Linda said.According to the report, Joshua showed his first notable improvement within a week of beginning treatment.Also read: Autism Care Begins Early: Why the First 1,000 Days Matter Most, Says AIIMS ExpertHow Does L1-79 Work?Yamo Pharmaceuticals describes L1-79 as a selective inhibitor of tyrosine hydroxylase, an enzyme involved in the production of dopamine and norepinephrine.The drug is intended to lower the production of these chemical messengers in an effort to regulate pathways that may contribute to sensory overload and social withdrawal in people with autism.Dr. Bartky said the drug differs from existing approaches because it aims to address core features of autism, including social interaction and communication.“What makes L1-79 different is that L1-79 treats the core symptoms of autism, things like socialization and communications, things that go along with that like eye contact, reciprocal conversation, nonverbal communication, such as reading social nuance. These are things that are extremely important for a person's emotional growth and functioning in society.”The response to treatment has varied among Dr. Bartky's patients, reflecting the wide range of symptoms associated with ASD.What Is The Status Of L1-79 Clinical Trials?Read More: Stem Cell Therapy For Autism: What India’s New Advisory Means For PatientsThere is currently no single medication that treats all the core features of autism spectrum disorder. Several medications are prescribed to manage particular behavioral patterns and associated conditions.L1-79 is being investigated as a potential treatment that could address autism's underlying neurological features. The Daily Mail reported that 116 patients had participated in L1-79's three clinical trials.The drug has received Fast Track designation from the US Food and Drug Administration (FDA). This program is intended to facilitate the development and review of treatments for serious conditions that address unmet medical needs.Although the designation does not shorten the clinical trial process, it can make a drug eligible for priority review. Under this pathway, the FDA aims to complete its review within six months, compared with the standard 10-month timeline. Are There Any Safety Concerns?Dr. Bartky also pointed to what he described as L1-79's safety profile.Some existing medications can cause serious side effects, including dyskinesia, which involves involuntary movements that can sometimes be permanent; metabolic syndrome, a group of conditions associated with increased risks of heart disease, stroke and type 2 diabetes; and hypertension. Dr. Bartky said L1-79 had “not had one single serious side effect.”

‘ozempic of autism’: experimental drug shows symptom improvements in nonverbal boy with asd

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

‘Ozempic Of Autism’: Experimental Drug Shows Symptom Improvements In Nonverbal Boy With ASD

Paper Straws Have 6.33 Times Higher Carcinogenic Risk Than Plastic Straws, Study Finds

US Bird Flu: Can H5N1 Trigger The Next Pandemic?

Experimental Male Contraceptive Pill May Immobilise Sperm, Work Within 30 Minutes & Give Protection For 8 Hours

Health Conditions A-Z

‘Ozempic Of Autism’: Experimental Drug Shows Symptom Improvements In Nonverbal Boy With ASD

Paper Straws Have 6.33 Times Higher Carcinogenic Risk Than Plastic Straws, Study Finds

Can Electrical Shocks To The Brain Reduce Men’s Tendency To Sexualise Women? New Study Finds Change